Overview

A Study for Patients With Type 1 Diabetes Mellitus

Status:
Completed
Trial end date:
2008-05-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to compare the human insulin inhalation powder plus insulin glargine with injected insulin (regular human insulin or insulin lispro) plus insulin glargine on lowering the blood sugar level.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Eli Lilly and Company
Collaborator:
Alkermes, Inc.
Treatments:
Insulin
Insulin Glargine
Insulin, Globin Zinc